Top Markets
Coin of the day
Lite Strategy, Inc. Lite Strategy, Inc.

Lite Strategy, Inc.

LITS
Rank in Stocks #27541
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm,... Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Share Price
$0.9474
Last synced: 2026-08-19
Market Cap
$32.24M
Change (1 day)
7.41%
Change (1 year)
-
Country
US
Trade Lite Strategy, Inc. (LITS)

Category

Earnings for Lite Strategy, Inc. (LITS)
Earnings in 2026 TTM: 0
According to Lite Strategy, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Lite Strategy, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$5.27B -
US
$-3.09B -
US
$1.95B -
NL
$1.61B -
AU
- -
CH